Quest Diagnostics Incorporated (DGX)
Profitability ratios
Return on sales
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 32.41% | 32.31% | 32.37% | 32.74% | 33.04% | 33.08% | 33.61% | 33.73% | 34.74% | 35.95% | 37.20% | 38.21% | 39.02% | 40.30% | 41.18% | 40.40% | 38.50% | 36.19% | 33.36% | 33.88% |
| Operating profit margin | 13.98% | 13.94% | 14.36% | 14.21% | 14.12% | 12.15% | 12.44% | 12.70% | 14.45% | 17.77% | 19.74% | 20.92% | 22.07% | 23.90% | 24.47% | 23.76% | 20.89% | 18.41% | 15.06% | 15.12% |
| Pretax margin | 11.90% | 11.67% | 11.94% | 12.05% | 12.21% | 10.81% | 11.14% | 11.07% | 12.53% | 15.82% | 18.25% | 22.71% | 24.09% | 25.85% | 26.71% | 23.14% | 19.96% | 17.39% | 12.89% | 12.81% |
| Net profit margin | 8.82% | 8.82% | 8.99% | 9.11% | 9.23% | 8.21% | 8.35% | 8.23% | 9.53% | 11.95% | 13.98% | 17.55% | 18.43% | 19.69% | 20.24% | 17.36% | 15.10% | 13.18% | 9.96% | 10.08% |
Quest Diagnostics Incorporated has shown fluctuations in its profitability ratios over the past few years.
1. Gross Profit Margin: The company's gross profit margin has been gradually declining from 33.88% as of March 31, 2020, to 32.41% as of December 31, 2024. This indicates a decrease in the percentage of revenue retained after deducting the cost of goods sold.
2. Operating Profit Margin: Similarly, the operating profit margin has experienced fluctuations, with a peak of 24.47% as of June 30, 2021, and a low of 12.15% as of September 30, 2023. This ratio reflects the company's ability to generate profits from its core operations.
3. Pre-Tax Margin: The pre-tax margin has also shown variation, with a high of 26.71% as of June 30, 2021, and a low of 10.81% as of September 30, 2023. This ratio indicates the company's efficiency in generating profits before taxes.
4. Net Profit Margin: The net profit margin has followed a similar trend, with a peak of 20.24% as of June 30, 2021, and a low of 8.21% as of September 30, 2023. This ratio reflects the company's overall profitability after all expenses have been accounted for.
Overall, Quest Diagnostics' profitability ratios have shown some volatility, potentially signaling challenges or changes in the company's operational efficiency and cost structures. Investors and stakeholders should monitor these ratios closely to assess the company's financial health and performance.
Return on investment
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 8.54% | 8.26% | 9.67% | 9.46% | 9.31% | 8.38% | 8.79% | 9.54% | 11.12% | 13.83% | 15.69% | 16.62% | 17.49% | 19.45% | 21.04% | 17.63% | 14.05% | 10.88% | 8.73% | 9.61% |
| Return on assets (ROA) | 5.39% | 5.23% | 6.05% | 6.06% | 6.09% | 5.66% | 5.90% | 6.17% | 7.34% | 9.30% | 11.11% | 13.94% | 14.61% | 16.03% | 17.40% | 12.88% | 10.16% | 7.79% | 5.77% | 6.41% |
| Return on total capital | 20.68% | 19.28% | 19.63% | 20.12% | 20.50% | 17.98% | 19.25% | 19.93% | 23.43% | 28.48% | 32.44% | 40.40% | 42.69% | 47.07% | 52.75% | 37.87% | 30.33% | 25.38% | 19.62% | 20.47% |
| Return on equity (ROE) | 12.85% | 12.35% | 12.69% | 13.15% | 13.54% | 11.88% | 12.67% | 13.06% | 15.99% | 19.73% | 23.07% | 29.39% | 30.85% | 34.03% | 37.94% | 26.60% | 21.08% | 17.22% | 12.86% | 13.65% |
Quest Diagnostics Incorporated has shown a consistent and strong performance in terms of profitability ratios over the past few years.
- Operating return on assets (Operating ROA) has followed an increasing trend from 9.61% in March 2020 to a peak of 21.04% in June 2021 before stabilizing around 8-9% in the most recent quarters of December 2024. This indicates the company's ability to generate profits from its operational assets over time.
- Return on assets (ROA) has also depicted a positive trajectory, climbing from 6.41% in March 2020 to 6.06% in March 2024. This ratio demonstrates Quest Diagnostics' efficiency in utilizing its total assets to generate earnings for its stakeholders.
- Return on total capital has shown a similar trend, reaching a high of 52.75% in June 2021 before moderating to around 19-20% by December 2024. This metric highlights the company's ability to generate returns for both debt and equity holders from its capital investments.
- Return on equity (ROE) has followed a similar pattern of steady growth, starting at 13.65% in March 2020 and reaching a peak of 37.94% in June 2021, before stabilizing around 12-13% in the most recent quarters of December 2024. This signifies Quest Diagnostics' efficiency in generating profits for its shareholders relative to their equity investments.
Overall, the profitability ratios of Quest Diagnostics demonstrate a strong performance, reflecting the company's effective utilization of assets and capital to generate returns for its stakeholders.